Stevanato Group S.p.A. STVN

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $21.14
Market Cap $5.90B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑7.4% YoY
$1.19B
3-Yr CAGR: 6.4%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↑115.2% YoY
$22.32M
FCF Yield: 0.38%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (STVN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2019
FY 2020 $662.0M $194.2M $155.7M $66.1M
FY 2021 $843.9M +27.5% $265.4M $133.3M $25.6M -61.2%
FY 2022 $983.7M +16.6% $319.8M $103.3M $-131.7M -613.6%
FY 2023 $1,085.4M +10.3% $339.9M $105.2M $-328.0M -149.0%
FY 2024 $1,104.0M +1.7% $302.3M $155.8M $-146.8M +55.2%
FY 2025 $1,186.3M +7.4% $343.9M $286.1M $22.3M +115.2%
$

Valuation

Market Price $21.14
Market Cap $5.90B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 3.88
FCF Yield 0.38%
Dividend Yield N/A
Shares Outstanding 273,003,700
%

Profitability & Margins

Gross Margin 28.99%
Operating Margin 0.69%
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.47x
Revenue 3-Yr CAGR 6.44%
🛡️

Financial Health & Liquidity

Current Ratio 18.09
Cash Ratio 2.50
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $130.60M
Total Debt N/A
Book Value / Share $5.45
💧

Cash Flow Efficiency

Operating Cash Flow $286.08M
Capital Expenditures (CapEx) $263.76M
Free Cash Flow $22.32M
OCF / Revenue 24.12%
FCF / Revenue 1.88%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $5.45
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $2.54B
Total Liabilities $1.06B
Stockholders' Equity $1.49B
Current Assets $943.35M
Current Liabilities $52.16M